ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
119.000 |
Evidence |
|
CSNK2B |
CSNK2B, CK2N, G5A: Casein kinase II subunit beta |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
117.000 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
117.000 |
Evidence |
|
FGFR1 |
FGFR1, FGFBR, FLG, FLT2: Basic fibroblast growth factor receptor 1 precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
117.000 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
STAT3 |
|
117.000 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
117.000 |
Evidence |
|
PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
PCBP1 |
PCBP1: Poly(rC)-binding protein 1 |
115.000 |
Evidence |
|
NRAS |
NRAS, HRAS1: GTPase NRas precursor |
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
114.000 |
Evidence |
O
|
PCNA |
PCNA: Proliferating cell nuclear antigen |
CCNB1 |
Cyclin B1 |
114.000 |
Evidence |
O
|
RAB5A |
RAB5A, RAB5: Ras-related protein Rab-5A |
GDI2 |
GDI2, RABGDIB: Rab GDP dissociation inhibitor beta |
112.000 |
Evidence |
O
|
GDI2 |
GDI2, RABGDIB: Rab GDP dissociation inhibitor beta |
RAB8B |
RAB8B: Ras-related protein Rab-8B |
112.000 |
Evidence |
O
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
112.000 |
Evidence |
|
PSMA5 |
PSMA5: Proteasome subunit alpha type-5 |
PSMB3 |
PSMB3: Proteasome subunit beta type-3 |
111.000 |
Evidence |
O
|
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
110.000 |
Evidence |
|
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
110.000 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
110.000 |
Evidence |
|
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
110.000 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
110.000 |
Evidence |
|
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
FXR2 |
FXR2, FMR1L2: Fragile X mental retardation syndrome-related protein 2 |
110.000 |
Evidence |
O
|
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
109.000 |
Evidence |
|
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
109.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
109.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
109.000 |
Evidence |
|
STXBP2 |
STXBP2, UNC18B: Syntaxin-binding protein 2 |
STX1A |
STX1A, STX1: Syntaxin-1A |
109.000 |
Evidence |
|
CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
109.000 |
Evidence |
O
|